Goldridge Terminal ロゴ Goldridge Terminal
人気
ログイン

ウォッチリストに追加
Proチャート

TriSalus Life Sciences In...

NasdaqGM: TLSIW · リアルタイム株価 · USD
1.25
+0.05 (4.17%)
終値時点： Aug 12, 2026, 3:36 PM

TriSalus Life Sciences Inc. (TLSIW) Stock Price, Analysis & Data

4.17%
買気配n/a
時価総額n/a
売上高（TTM）45.08M
純利益（TTM）-57.25M
ベータ0.43
EPS（TTM）n/a
PER（TTM）n/a
予想PERn/a
PBR（TTM）5.98
PSR（TTM）n/a
Earnings Daten/a
売気配n/a
出来高2,708
平均出来高（20日）4,796
始値1.11
前日終値1.20
当日レンジ1.20 - 1.25
52週レンジ0.44 - 2.29
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

TLSIWについて

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures...

[続きを読む]
業種
セクター
IPO日 Feb 9, 2021
従業員数 102
上場取引所 NasdaqGM
ティッカー TLSIW
ウェブサイト https://trisaluslifesci.com
企業情報の全文

業績

2025年のTriSalus Life Sciencesの売上高は45.15Mで、前年の29.43Mから53.41%の増加でした。 利益は-39.23Mで、30.56%の増加でした。

財務諸表
news image

5日前 · MarketBeat

TriSalus Life Sciences Q2 Earnings Call Highlights

TriSalus Life Sciences (NASDAQ:TLSI) reported second-quarter revenue of $11.4 million, up 1.7% from $11.2 million a year earlier, as demand for its TriNav pressure-enabled drug delivery system increas...

news image

5日前 · GuruFocus.com

TriSalus Life Sciences Inc (TLSI) (Q2 2026) Earnings Call Highlights: New CMS G-code Expands ...

TriSalus Life Sciences Inc (TLSI) reiterates full-year guidance as reimbursement breakthrough in office-based labs and robust clinical pipeline position the company for accelerated back-half growth.

news image

3か月前 · GuruFocus.com

TriSalus Life Sciences Inc (TLSI) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...

TriSalus Life Sciences Inc (TLSI) navigates commercial growth and FDA delays while showcasing improved margins and robust clinical data.

news image

3か月前 · MarketBeat

TriSalus Life Sciences Q1 Earnings Call Highlights

TriSalus Life Sciences (NASDAQ:TLSI) reported slightly lower first-quarter revenue and reduced its full-year 2026 revenue outlook, citing disruption from a broad commercial reorganization and a delaye...

news image

3か月前 · Moby

TriSalus Life Sciences, Inc. Q1 2026 Earnings Call Summary

Moby summary of TriSalus Life Sciences, Inc.'s Q1 2026 earnings call

2ページ中1ページ